Access to anti-retroviral drugs, male in Netherlands
Netherlands: Access to anti-retroviral drugs, male was 89.0% in 2023. ▲ Rising
Access to anti-retroviral drugs, male in Netherlands, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
Netherlands recorded 89.0% for access to anti-retroviral drugs, male in 2023. That is the highest value across all 24 years on record.
The figure is up 1.1% on the previous year and up 21.9% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Netherlands peaked at 89.0% in 2023 and was at its lowest, 45.0%, in 2000.
That places Netherlands 17th out of 141 countries with data for 2023, putting it in the top quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Access to anti-retroviral drugs, male in Netherlands, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 45.0% | — |
| 2001 | 47.0% | +4.4% |
| 2002 | 49.0% | +4.3% |
| 2003 | 49.0% | +0.0% |
| 2004 | 49.0% | +0.0% |
| 2005 | 50.0% | +2.0% |
| 2006 | 51.0% | +2.0% |
| 2007 | 53.0% | +3.9% |
| 2008 | 56.0% | +5.7% |
| 2009 | 59.0% | +5.4% |
| 2010 | 63.0% | +6.8% |
| 2011 | 66.0% | +4.8% |
| 2012 | 69.0% | +4.5% |
| 2013 | 73.0% | +5.8% |
| 2014 | 77.0% | +5.5% |
| 2015 | 80.0% | +3.9% |
| 2016 | 82.0% | +2.5% |
| 2017 | 85.0% | +3.7% |
| 2018 | 86.0% | +1.2% |
| 2019 | 87.0% | +1.2% |
| 2020 | 88.0% | +1.1% |
| 2021 | 88.0% | +0.0% |
| 2022 | 88.0% | +0.0% |
| 2023 | 89.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 50.8% | 45.0% | 59.0% | 10 |
| 2010s | 76.8% | 63.0% | 87.0% | 10 |
| 2020s | 88.2% | 88.0% | 89.0% | 4 |
Countries ranked near Netherlands
More gender data for Netherlands
- Child population (UN estimates and projections) 2,769 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.232 % change on previous year (2030)
- Population 15,988 (2030)
- Working-age population (UN estimates and projections) 15,988 (2030)
- Population (UN estimates and projections), annual growth rate 0.366 % change on previous year (2030)
- Age population, age 00, female, interpolated 85,418 (2025)
- Age population, age 00, male, interpolated 89,789 (2025)
- Age population, age 01, female, interpolated 85,046 (2025)
- Age population, age 01, male, interpolated 89,271 (2025)
- Age population, age 02, female, interpolated 86,477 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Netherlands?
- Access to anti-retroviral drugs, male in Netherlands was 89.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Netherlands?
- The highest recorded value was 89.0% in 2023.
- What is the lowest access to anti-retroviral drugs, male recorded in Netherlands?
- The lowest recorded value was 45.0% in 2000.
- How does Netherlands rank for access to anti-retroviral drugs, male?
- Netherlands ranks 17th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, male rising or falling in Netherlands?
- Over the last ten years it is up 21.9%. The long-run trend across the full record is rising.
- Where does this Netherlands data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.